ID   U2OS SQSTM1 KO
AC   CVCL_A6LP
DR   Wikidata; Q107117178
RX   PubMed=39006307;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=39006307; DOI=10.12688/f1000research.132628.2; PMCID=PMC11240082;
RA   Ayoubi R., Alshafie W., Shlaifer I., Southern K., McPherson P.S.,
RA   Laflamme C.;
RG   NeuroSGC/YCharOS/EDDU Collaborative Group;
RT   "The identification of high-performing antibodies for sequestosome-1
RT   for use in western blot, immunoprecipitation and immunofluorescence.";
RL   F1000Research 12:324.1-324.14(2023).
//